ACTOS

This brand name is authorized in Austria, Australia, Estonia, Spain, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug ACTOS contains one active pharmaceutical ingredient (API):

1 Pioglitazone UNII JQT35NPK6C - PIOGLITAZONE HYDROCHLORIDE

Pioglitazone effects may be mediated by a reduction of insulin resistance. Pioglitazone appears to act via activation of specific nuclear receptors (peroxisome proliferator activated receptor gamma) leading to increased insulin sensitivity of liver, fat and skeletal muscle cells in animals. Treatment with pioglitazone has been shown to reduce hepatic glucose output and to increase peripheral glucose disposal in the case of insulin resistance. Read about Pioglitazone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACTOS Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
ACTOS Tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BG03	Pioglitazone	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones
Discover more medicines within A10BG03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8694N, 8695P, 8696Q
Country: EE	Ravimiamet	Identifier(s): 1013566, 1013577, 1013588, 1209372, 1209383, 1209394, 1209406, 1209417, 1209428, 1209439, 1212411, 1212422, 1212433, 1212444, 1212455, 1212466, 1212477, 1212488, 1212499, 1212501, 1212512, 1212523, 1212534, 1212545, 1494402, 1494413, 1494424, 1494435, 1494446, 1494457
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00150001, 00150004, 00150004IP, 00150009, 00150010, 00150010IP
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 140403, 140405, 161338, 175725, 175728, 178953, 180500, 198640, 20095, 20096, 374281, 374283, 374285, 51997
Country: HK	Department of Health Drug Office	Identifier(s): 47882, 47884
Country: IE	Health Products Regulatory Authority	Identifier(s): 10330, 10378, 10506, 10568, 10594, 10609, 10661, 10756, 10761, 10797, 10798, 15530, 15590
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7091, 7092, 7093
Country: IT	Agenzia del Farmaco	Identifier(s): 034946018, 034946044, 034946121
Country: JP	医薬品医療機器総合機構	Identifier(s): 3969007F1024, 3969007F2020, 3969007F3027, 3969007F4023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004071, 1004363, 1004508, 1026399, 1026400, 1026401, 1026402, 1026403, 1026404, 1026405, 1026406, 1026407, 1026408, 1026409, 1026410, 1026411, 1026412, 1026413, 1026414, 1026415, 1026416, 1026417, 1026418, 1026419, 1063617, 1063618, 1063619, 1063620, 1063621, 1063622
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 84247, 84255
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100308456, 100308462, 100308479
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W08069001, W08069002, W08069003, W08069004, W08069005, W08069006, W08069007, W08069008, W08070001, W08070003, W08070004, W08070005, W08070006, W08070007, W08070008, W08070009, W08071001, W08071002, W08071003, W08071004, W08071005, W08071006, W08071007, W08071008
Country: SG	Health Sciences Authority	Identifier(s): 12441P, 12442P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5063311, 5063312
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8682758010016, 8682758010023
Country: US	FDA, National Drug Code	Identifier(s): 64764-151, 64764-301, 64764-451